BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6722792)

  • 1. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
    Kinahan JJ; Otten M; Grindey GB
    Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of deoxycytidine rescue of thymidine toxicity in human T-leukemic lymphocytes.
    Fox RM; Tripp EH; Tattersall MH
    Cancer Res; 1980 May; 40(5):1718-21. PubMed ID: 6989492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of uridine triphosphate in the phosphorylation of 1-beta-D-arabinofuranosylcytosine by Ehrlich ascites tumor cells.
    White JC; Hines LH
    Cancer Res; 1987 Apr; 47(7):1820-4. PubMed ID: 3028615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; VeselĂ˝ J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
    Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
    Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
    Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
    Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
    Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of a new antitumor agent, carbetimer.
    Ardalan B; Paget GE
    Cancer Res; 1986 Nov; 46(11):5473-6. PubMed ID: 3756894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
    Grant S; Cadman E
    Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic mutants of Chinese hamster cells with altered cytidine 5'-triphosphate synthetase.
    Chu EH; McLaren JD; Li IC; Lamb B
    Biochem Genet; 1984 Aug; 22(7-8):701-15. PubMed ID: 6497832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
    Fridland A
    Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of thymidine on deoxyribonucleotide pool levels, cytotoxicity and mutation induction in Friend mouse erythroleukaemia cells.
    Wilkinson YA; McKenna PG
    Leuk Res; 1989; 13(7):615-20. PubMed ID: 2761292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD; Smith PA; Levy EJ; Handschumacher RE
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
    Moriconi WJ; Slavik M; Taylor S
    Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.